FindTrial
Sign In

Exploring the Effects and Mechanisms of Electroacupuncture Preconditioning at Zusanli (ST36) and Feishu (BL13) on Reducing Postoperative Pulmonary Complications (PPCs) in Laparoscopic Upper Abdominal Surgery: A Case-Control Study Based on the Theory of "Lung and Large Intestine Being Internally and Externally Related"

Exploring the Effects and Mechanisms of Electroacupuncture Preconditioning at Zusanli (ST36) and Feishu (BL13) on Reducing Postoperative Pulmonary Complications (PPCs) in Laparoscopic Upper Abdominal Surgery Based on the Theory of "The Lung and Large Intestine Being Internally and Externally Related"

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001490
Enrollment
Unknown
Registered
2026-06-10
Start date
2026-01-08
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pulmonary Complications (PPCs)

Interventions

EA group:electroacupuncture preconditioning:Using Huatuo SDZ-V electroacupuncture stimulator, electroacupuncture at Feishu (BL13) and Zusanli (ST36) acupoints with 2/10 Hz sparse-dense wave. Stimulati
C group:Acupoint plaster application without electrical stimulation. At the same time points (16:00 on the day before surgery and before anesthesia induction on the day of surgery), sterile plasters w

Sponsors

People's Hospital of Shizhu Tujia Autonomous County
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1.Age = 18 years old. 2.Scheduled for elective laparoscopic upper abdominal surgery (gastric/hepatic/pancreatic/gallbladder resection). 3.Patients with intermediate risk or higher according to the ARISCAT score. 4.American Society of Anesthesiologists (ASA) physical status classification I-III. 5.Signed informed consent form.

Exclusion criteria

Exclusion criteria: 1.Received mechanical ventilation for more than 1 hour within 2 weeks before surgery. 2.Acute respiratory failure (pneumonia, ALI or ARDS). 3.Progressive neuromuscular disease. 4.Refusal to participate or currently participating in another interventional study.

Design outcomes

Primary

MeasureTime frame
incidence of PPCs within 7 days after surgery;—

Secondary

MeasureTime frame
Postoperative recovery indices;overall postoperative complication rate;postoperative mortality rate;diaphragmatic ultrasound monitoring;Lung Ultrasound Score;plasma inflammatory markers;—

Countries

China

Contacts

Public ContactYang Tingjun

People's Hospital of Shizhu Tujia Autonomous County, Chongqing

65755604@qq.com15223928822

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 29, 2026